Welcome

Breast Cancer News

Tuesday, June 22, 2010
Sequential Chemotherapy Benefits Node-positive Breast Cancer Patients: "Women with operable node positive breast cancer experienced a survival benefit from sequential administration of doxorubicin, cyclophosphamide, and Taxotere® (docetaxel). These findings were recently published in The New England Journal of Medicine. 1 Effective treatment of node positive breast cancer ..."

No comments: